Name
Osaühing Pelgulinna Apteek
Registry code
10198380
VAT number
EE100531356
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
17.04.1997 (27)
Financial year
01.01-31.12
Capital
12 782.00 €
Activity
47731 - Dispensing chemist in specialised stores
476 465 €
-22 778 €
-5%
1 060 €
(estimate is approximate)
-62 289 €
3
Submitted
No tax arrears
37%
-58%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Tiina Järve 31.01.1951 (73) | 70% - 8 947.00 EUR | Board member | Direct ownership | |
| Karin Alamaa-Aas 23.04.1975 (49) | 30% - 3 835.00 EUR | Board member | Direct ownership |
| 2019 30.06.2020 | 2020 29.06.2021 | 2021 01.07.2022 | 2022 06.07.2023 | 2023 28.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 722 224 € | 496 523 € | 299 086 € | 401 234 € | 476 465 € |
| Net profit (loss) for the period | -42 523 € | -34 992 € | -44 230 € | -41 710 € | -22 778 € |
| Profit Margin | -6% | -7% | -15% | -10% | -5% |
| Current Assets | 119 651 € | 87 825 € | 54 866 € | 55 136 € | 35 110 € |
| Fixed Assets | 9 824 € | 7 368 € | 7 368 € | 6 072 € | 4 276 € |
| Total Assets | 129 475 € | 95 193 € | 62 234 € | 61 208 € | 39 386 € |
| Current Liabilities | 48 053 € | 48 763 € | 48 034 € | 86 218 € | 87 175 € |
| Non Current Liabilities | - | - | 12 000 € | 14 500 € | 14 500 € |
| Total Liabilities | - | - | 60 034 € | 100 718 € | 101 675 € |
| Share Capital | - | - | - | - | - |
| Equity | 81 422 € | 46 430 € | 2 200 € | -39 510 € | -62 289 € |
| Employees | 7 | 6 | 6 | 3 | 3 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 105 371.61 € | 5 129.15 € | 3 661.7 € | 4 |
| 2023 Q4 | 116 860.84 € | 7 405.54 € | 4 812.73 € | 4 |
| 2023 Q3 | 114 076.84 € | 7 009.83 € | 4 932.09 € | 5 |
| 2023 Q2 | 135 821.35 € | 7 087.37 € | 4 565.8 € | 5 |
| 2023 Q1 | 118 847.39 € | 6 435.05 € | 4 443.03 € | 5 |
| 2022 Q4 | 122 106.56 € | 6 149.21 € | 4 741.47 € | 5 |
| 2022 Q3 | 87 057.2 € | 6 080.64 € | 4 811.97 € | 5 |
| 2022 Q2 | 112 672.05 € | 6 878.38 € | 4 926.27 € | 5 |
| 2022 Q1 | 47 251.14 € | 4 056.37 € | 3 793.55 € | 5 |
| 2021 Q4 | - | 1 381.22 € | 1 459.6 € | 5 |
| 2021 Q3 | 59 244.33 € | 8 989.39 € | 7 822.44 € | 5 |
| 2021 Q2 | 150 916.19 € | 7 470.81 € | 7 503.27 € | 7 |
| 2021 Q1 | 121 112.15 € | 8 509.93 € | 7 677.12 € | 7 |
| 2020 Q4 | 145 025.44 € | 8 011.92 € | 7 796.04 € | 7 |
| 2020 Q3 | 115 215.33 € | 5 816.56 € | 5 622.67 € | 7 |
| 2020 Q2 | 116 973.12 € | 8 220.21 € | 8 064.5 € | 7 |
| 2020 Q1 | 135 944.54 € | 9 797.2 € | 8 613.84 € | 8 |
